Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fusion | 7 | 2024 | 1281 | 1.440 |
Why?
|
| Lumbar Vertebrae | 6 | 2024 | 1868 | 1.110 |
Why?
|
| Costs and Cost Analysis | 6 | 2024 | 1677 | 0.970 |
Why?
|
| Interviews as Topic | 2 | 2018 | 2659 | 0.660 |
Why?
|
| Spinal Cord Diseases | 4 | 2024 | 293 | 0.650 |
Why?
|
| Orthopedics | 5 | 2022 | 892 | 0.630 |
Why?
|
| Hospital Costs | 1 | 2024 | 976 | 0.590 |
Why?
|
| Bone Screws | 2 | 2019 | 530 | 0.560 |
Why?
|
| Tibia | 2 | 2019 | 1065 | 0.480 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2024 | 8158 | 0.420 |
Why?
|
| Internship and Residency | 5 | 2022 | 5870 | 0.380 |
Why?
|
| Spondylosis | 2 | 2020 | 85 | 0.350 |
Why?
|
| Surgical Flaps | 1 | 2019 | 1669 | 0.340 |
Why?
|
| Fractures, Compression | 2 | 2022 | 129 | 0.340 |
Why?
|
| Laminectomy | 3 | 2024 | 224 | 0.300 |
Why?
|
| Natural Language Processing | 3 | 2020 | 1135 | 0.280 |
Why?
|
| Osteoporotic Fractures | 2 | 2022 | 409 | 0.270 |
Why?
|
| Cervical Vertebrae | 4 | 2024 | 978 | 0.240 |
Why?
|
| Spinal Fractures | 2 | 2022 | 702 | 0.240 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 2363 | 0.220 |
Why?
|
| Cannabidiol | 1 | 2024 | 117 | 0.200 |
Why?
|
| Cannabinoids | 1 | 2024 | 173 | 0.190 |
Why?
|
| Kyphoplasty | 1 | 2022 | 44 | 0.190 |
Why?
|
| Diskectomy | 2 | 2021 | 209 | 0.190 |
Why?
|
| Lordosis | 1 | 2022 | 92 | 0.190 |
Why?
|
| Blood Patch, Epidural | 1 | 2021 | 56 | 0.190 |
Why?
|
| Dura Mater | 1 | 2021 | 290 | 0.160 |
Why?
|
| Students, Medical | 3 | 2018 | 1927 | 0.160 |
Why?
|
| Bone Transplantation | 1 | 2024 | 922 | 0.160 |
Why?
|
| Spinal Curvatures | 1 | 2019 | 67 | 0.160 |
Why?
|
| Spine | 3 | 2022 | 1111 | 0.160 |
Why?
|
| Spinal Injuries | 1 | 2022 | 300 | 0.160 |
Why?
|
| School Admission Criteria | 2 | 2016 | 105 | 0.150 |
Why?
|
| Risk Adjustment | 1 | 2020 | 601 | 0.140 |
Why?
|
| Job Application | 1 | 2016 | 38 | 0.140 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 247 | 0.140 |
Why?
|
| Cadaver | 2 | 2019 | 1345 | 0.130 |
Why?
|
| Wounds, Gunshot | 1 | 2022 | 581 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 694 | 0.130 |
Why?
|
| Pelvic Bones | 1 | 2017 | 270 | 0.120 |
Why?
|
| Retrospective Studies | 15 | 2024 | 80372 | 0.120 |
Why?
|
| Spinal Cord Injuries | 1 | 2022 | 924 | 0.120 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 413 | 0.110 |
Why?
|
| Spinal Diseases | 1 | 2018 | 559 | 0.110 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 1736 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 926 | 0.100 |
Why?
|
| Decompression | 2 | 2020 | 38 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2020 | 1600 | 0.090 |
Why?
|
| Swine | 2 | 2019 | 5899 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 14660 | 0.080 |
Why?
|
| Adult | 17 | 2024 | 219994 | 0.070 |
Why?
|
| Rats | 1 | 2024 | 23711 | 0.070 |
Why?
|
| Humans | 31 | 2024 | 760621 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2781 | 0.070 |
Why?
|
| Bone Density | 1 | 2019 | 3534 | 0.070 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2009 | 423 | 0.060 |
Why?
|
| Male | 14 | 2024 | 359744 | 0.060 |
Why?
|
| Neurosurgical Procedures | 3 | 2021 | 2056 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2020 | 15697 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2017 | 2041 | 0.060 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 3164 | 0.060 |
Why?
|
| Intraoperative Complications | 2 | 2021 | 1186 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3763 | 0.060 |
Why?
|
| Length of Stay | 1 | 2017 | 6479 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 20080 | 0.050 |
Why?
|
| Aged | 7 | 2024 | 169152 | 0.050 |
Why?
|
| New Zealand | 1 | 2021 | 355 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 4810 | 0.040 |
Why?
|
| Animals | 3 | 2024 | 167963 | 0.040 |
Why?
|
| Reoperation | 2 | 2020 | 4291 | 0.040 |
Why?
|
| Female | 12 | 2024 | 391270 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2022 | 65017 | 0.040 |
Why?
|
| Vancomycin | 1 | 2022 | 503 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7818 | 0.040 |
Why?
|
| Information Systems | 1 | 2020 | 398 | 0.040 |
Why?
|
| Hip | 1 | 2019 | 251 | 0.040 |
Why?
|
| Middle Aged | 6 | 2024 | 220352 | 0.040 |
Why?
|
| Neck | 1 | 2022 | 731 | 0.040 |
Why?
|
| Prescriptions | 1 | 2019 | 388 | 0.040 |
Why?
|
| Illinois | 1 | 2017 | 118 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 36290 | 0.040 |
Why?
|
| Utilization Review | 1 | 2017 | 383 | 0.030 |
Why?
|
| Personnel Selection | 1 | 2016 | 193 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2020 | 54303 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20509 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2022 | 1527 | 0.030 |
Why?
|
| Diabetic Retinopathy | 2 | 1992 | 1268 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2017 | 2295 | 0.020 |
Why?
|
| Vision Screening | 1 | 1992 | 69 | 0.020 |
Why?
|
| Age Distribution | 1 | 2017 | 2893 | 0.020 |
Why?
|
| Pancreas Transplantation | 1 | 1991 | 196 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1721 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2017 | 1405 | 0.020 |
Why?
|
| Algorithms | 2 | 2020 | 13981 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 41335 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2017 | 2881 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2020 | 3323 | 0.020 |
Why?
|
| Endocrinology | 1 | 1991 | 443 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 87810 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8624 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 15687 | 0.010 |
Why?
|
| Peptides | 1 | 1992 | 4354 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 1263 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1992 | 6381 | 0.010 |
Why?
|
| Insulin | 1 | 1992 | 6597 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1991 | 3455 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29658 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1991 | 4215 | 0.010 |
Why?
|
| Light Coagulation | 1 | 1992 | 71 | 0.010 |
Why?
|
| Risk Factors | 2 | 2017 | 74359 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 58995 | 0.010 |
Why?
|
| Depth Perception | 1 | 1991 | 94 | 0.010 |
Why?
|
| Glucagon-Like Peptides | 1 | 1992 | 159 | 0.010 |
Why?
|
| Ophthalmoscopy | 1 | 1991 | 171 | 0.010 |
Why?
|
| Glucagon | 1 | 1992 | 532 | 0.010 |
Why?
|
| Quality of Life | 1 | 1991 | 13308 | 0.010 |
Why?
|
| Fundus Oculi | 1 | 1991 | 541 | 0.010 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 1992 | 366 | 0.010 |
Why?
|
| Perceptual Disorders | 1 | 1991 | 197 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 1628 | 0.000 |
Why?
|
| Photography | 1 | 1991 | 530 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1992 | 12293 | 0.000 |
Why?
|
| Creatinine | 1 | 1991 | 1903 | 0.000 |
Why?
|
| Fasting | 1 | 1992 | 1603 | 0.000 |
Why?
|
| Eating | 1 | 1992 | 1539 | 0.000 |
Why?
|
| Reference Values | 1 | 1992 | 4925 | 0.000 |
Why?
|
| Ophthalmology | 1 | 1991 | 549 | 0.000 |
Why?
|
| Kinetics | 1 | 1992 | 6377 | 0.000 |
Why?
|
| Triglycerides | 1 | 1991 | 2476 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1991 | 1182 | 0.000 |
Why?
|
| Cholesterol | 1 | 1991 | 2924 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1991 | 2643 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5125 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1992 | 5508 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1991 | 4426 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1991 | 3598 | 0.000 |
Why?
|
| Time Factors | 1 | 1992 | 40165 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1991 | 39261 | 0.000 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_